Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 3, 1997, Pages 1030-1037

  Lake, Kristy D ^a   Compton, David R ^a   Varga, Karoly ^a   Martin, Billy R ^a   Kunos, George ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; DEXANABINOL; DRONABINOL; PALMITOYLETHANOLAMINE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTERIAL PRESSURE; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENCY; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOLECULAR INTERACTION; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; STEREOCHEMISTRY;

ANIMALS; BRADYCARDIA; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTENSION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0030925426     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. 9-tetrahydrocannabinol in the rat. J. Pharmacol. Exp. Ther. 196: 649-656, 1976.
2. ADAMS, M. D., EARNHARDT, J. T., MARTIN, B. R., HARRIS, L. S., DEWEY, W. L. AND RAZDAN, R. K.: A cannabinoid with cardiovascular activity but no overt behavioral effects. Experientia 33: 1204-1205, 1977.
3. 9-tetrahydrocannabinol of the blood pressure of hypertensive rats bearing regenerated adrenal glands. Br. J. Pharmacol. 48: 169-171, 1973.
4. 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 263: 1118-1126, 1992a.
5. COMPTDN, D. R., JOHNSON, M. R., MELVIN, L. S. AND MARTIN, B. R.: Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as Cannabimimetic agents. J. Pharmacol. Exp. Ther. 260: 201-209, 1992b.
6. COMPTON, D. R., RICE, K. C., DE COSTA, B. R., RAZDAN, R. K., MELVIN, L. S., JOHNSON, M. R. AND MARTIN, B. R.: Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265: 218-226, 1993.
7. 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther. 277: 586-594, 1996.
8. DELEAN, A., MUNSON, P. AND RODBARD, D.: Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235: E97-E102, 1977.
9. DEVANE, W. A., DYSARZ, F. A., JOHNSON, M. R., MELVIN, L. S. AND HOWLETT, A. C.: Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34: 605-613, 1988.
10. DEVANE, W. A., HANUS L., BREUER A., PERTWEE R. G., STEVENSON L. A., GRIFFIN G., GIBSON D., MANDELBAUM A., ETINGER A. AND MECHOULAM R.: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949, 1992.
11. DEWEY, W. L., HARRIS, L. S., HOWES, J. F., KENNEDY, J. S., GRANCHELLI, F. E., PARS, H. G. AND RAZDAN, R. K.: Pharmacology of some marijuana constituents and two heterocyclic analogues. Nature 226: 1265-1276, 1970.
12. 9(11)-tetrahydrocannabinol and their interaction with epinephrine. Life Sci. 41: 79-87, 1987.
13. FACCI L., TOSO, D., ROMANELLO, S., BURIANI, A., SKAPER, S. D. AND LEON, A.: Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. U.S.A. 92: 3376-3380, 1995.
14. FELDER, C. C., BRILEY, E. M., AXELROD, J., SIMPSON, J. T., MACKIE, K. AND DEVANE, W. A.: Anandamide, an endogenous Cannabimimetic eicosanoid. binds to the cloned human receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A. 90: 7656-7660, 1993.
15. FRIDE, E. AND MECHOULAM, R.: Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231: 313-314, 1993.
16. GALIEGUE, S., MARY, S., MARCHAND, J., DUSSOSSOY, D., CARRIERE, D., CARAYON, P., BOUBOULA, M., SHIRE, D., LE FUR, G. AND CASELLAS, P.: Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232: 54-61, 1995.
17. GERARD, C. M., MOLLEREAU, C., VASSART, G. AND PARMENTIER, M.: Molecular cloning of a human brain cannabinoid receptor which is also expressed in testis. Biochem. J. 279: 129-134, 1991.
18. GRAHAM, J. D. P. AND LI D. M. F.: Cardiovascular and respiratory effects of cannabis in cat and rat. Br. J. Pharmacol. 49: 1-10, 1973.
19. HERKENHAM, M., LYNN, A. B., LITTLE, M. D., JOHNSON, M. R., MELVIN, L. S., DE COSTA, B. R. AND RICE, K. C.: Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A. 87: 1932-1936, 1990.
20. ISHAC, E. J. N., JIANG, L., LAKE, K. D., VARGA, K., ABOOD, M. A. AND KUNOS, G.: Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol. 118: 2023-2028, 1996.
21. KUSTER, J. E., STEVENSON, J. L, WARD, S. J., D'AMBRA, T. E. AND HAYCOCK, D. A.: Aminoalkylindole binding in rat cerebellum: Selective displacement by natural and synthetic cannabinoids. J. Pharmacol. Exp. Ther. 264: 1352-1363, 1993.
22. LAKE K. D., MARTIN, B. R., KUNOS, G. AND VARGA, K.: Cardiovascular effects of anandamide in anesthetized and conscious normotensive and spontaneously hypertensive rats. Hypertension. In press, 1997.
23. 8-THC-dimethylheptyl in mice and dogs. Pharmacol. Biochem. Behav. 32: 661-666, 1989.
24. LITTLE, P. J., COMPTON, D. R., JOHNSON, M. R., MELVIN, L. S. AND MARTIN, B. R.: Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J. Pharmacol. Exp. Ther. 247: 1046-11051, 1988.
25. MAGGI, C. A. AND MELI A.: Suitability of urethane for physio-pharmacological investigations in various systems. Experientia 42: 109-115, 1986.
26. MATSUDA, L. A., LOLAIT, S. J., BROWNSTEIN, M. J., YOUNG, A. C. AND BONNER, T. L: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564, 1990.
27. MECHOULAM, R., DEVANE, W. A. AND GLASER, R.: Cannabinoid geometry and biological activity. In: Marijuana/cannabinoids: neurobiology and neurophysiology, ed. by L. Murphy and A. Bartke, pp. 1-33, CRC Press, Boca Raton, FL, 1992.
28. MUNRO, S., THOMAS, K. L. AND ABU-SHAAR, M.: Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65, 1993.
29. NAHAS, G. G., SCHWARTZ, I. W., ADAMEC, J. AND MANGER, W. M.: Tolerance to delta-9-tetrahydrocannabinol in the spontaneously hypertensive rat. Proc. Soc. Exp. Biol. Med. 142: 58-60, 1973.
30. RINALDI-CARMONA, M., BARTH F., HEAULME M., SHIRE D., CALANDRA B., CONGY C., MARTINEZ S., MARUANI J., NELIAT G., CAPUT D., FERRARA P., SOUBRIE P., BRELIERE J. C. AND LE FUR G.: SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350: 240-244, 1994.
31. SHIRE, D., CARILLON, C., KAGHAD, M., CALANDRA, B., RINALDI-CARMONA, M., LEFUR, G. AND FERRARA, P.: An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270: 3726-3731, 1995.
32. 2): Identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278: 989-999, 1996.
33. 9-tetrahydrocannabinol on the rat blood pressure. Eur. J. Pharmacol. 58: 351-357.
34. SMITH, P. B., COMPTON D. R., WELCH S. P., RAZDAN R. K., MECHOULAM R. AND MARTIN B. R.: The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270: 219-227, 1994.
35. STARK, P. AND DEWS, P. B.: Cannabinoids II. Cardiovascular effects. J. Pharmacol. Exp. Ther. 214: 131-138, 1980.
36. 1 cannabinoid receptor in the hypotensive action of anandamide. Eur. J. Pharmacol. 278: 279-283, 1995.
37. VARGA, K., LAKE, K. D., HUANGFU, D., GUYENET, P. G. AND KUNOS, G.: Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28: 682-686, 1996.
38. VOGEL, Z., BARG, J., LEVY, R., SAVA, D., HELDMAN, E. AND MECHOULAM, R.: Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem. 61: 352-35, 1993.
39. 9-trans-tetrahydrocannabinol. J. Pharm. Pharmacol. 26: 186-198, 1974.
40. 9-trans-tetrahydrocannabinol: A hypotensive effect in rats. Psychopharmacology 28: 269-274, 1973.
41. 8-tetrahydrocannabinol-dimethylheptyl in rats. J. Cardiovasc. Pharmacol. 28: 332-336, 1996.
42. ZAUGG, H. E. AND KYNCL J.: New antihypertensive cannabinoids. J. Med. Chem. 26: 214-217, 1983.